© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
Dr Clare Craig explains why the FDA should NOT have granted approval for roll-out in the 6 month to 4 yr old children cohort
This trial should have been deemed null and void.
The regulators are failing to do their job.
The FDA voted unanimously to approve the drug for this age group. Given the problems outlined, this is unbelievable.





